Mail

UK markets closed

FTSE 100
7,895.85
+18.80(+0.24%)
FTSE 250
19,391.30
-59.37(-0.31%)
AIM
745.67
+0.38(+0.05%)
GBP/EUR
1.1607
-0.0076(-0.65%)
GBP/USD
1.2370
-0.0068(-0.55%)
Bitcoin GBP
51,604.84
+670.98(+1.32%)

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

BlackRock Health Sciences Trust (BME)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

38.80

+0.06

(+0.15%)

At close: 04:00PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	540.19M
Enterprise value	N/A
Trailing P/E	26.90
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	26.47
Price/book (mrq)	0.92
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.68
52-week change ³	-8.72%
S&P500 52-week change ³	21.23%
52-week high ³	43.20
52-week low ³	35.53
50-day moving average ³	41.26
200-day moving average ³	39.91

Share statistics

Avg vol (3-month) ³	31.46k
Avg vol (10-day) ³	34.88k
Shares outstanding ⁵	13.94M
Implied shares outstanding ⁶	13.94M
Float ⁸	N/A
% held by insiders ¹	0.00%
% held by institutions ¹	20.58%
Shares short (28 Mar 2024) ⁴	8.81k
Short ratio (28 Mar 2024) ⁴	0.27
Short % of float (28 Mar 2024) ⁴	0.06%
Short % of shares outstanding (28 Mar 2024) ⁴	0.06%
Shares short (prior month 29 Feb 2024) ⁴	14.03k

Dividends & splits

Forward annual dividend rate ⁴	2.56
Forward annual dividend yield ⁴	6.60%
Trailing annual dividend rate ³	2.56
Trailing annual dividend yield ³	6.60%
5-year average dividend yield ⁴	5.83
Payout ratio ⁴	177.50%
Dividend date ³	31 Jan 2019
Ex-dividend date ⁴	12 Apr 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	244.30%
Operating margin (ttm)	21.14%

Management effectiveness

Return on assets (ttm)	0.21%
Return on equity (ttm)	3.37%

Income statement

Revenue (ttm)	8.19M
Revenue per share (ttm)	0.59
Quarterly revenue growth (yoy)	-0.80%
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	20.02M
Diluted EPS (ttm)	1.44
Quarterly earnings growth (yoy)	-75.70%

Balance sheet

Total cash (mrq)	534
Total cash per share (mrq)	0
Total debt (mrq)	60.69k
Total debt/equity (mrq)	0.01%
Current ratio (mrq)	0.20
Book value per share (mrq)	42.18

Cash flow statement

Operating cash flow (ttm)	32.02M
Levered free cash flow (ttm)	4.66M